Aug 11, 2026 11:00AM
Aug 11, 2026 08:01AM
Aug 11, 2026 07:30AM
Aug 4, 2026 08:00AM
May 20, 2026 09:37AM
May 7, 2026 04:47PM
May 7, 2026 04:06PM Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Mar 27, 2026 04:12PM
Nov 7, 2025 04:41PM
Nov 6, 2025 04:02PM
Aug 20, 2025 07:37AM
Aug 12, 2025 03:16PM
Aug 7, 2025 04:06PM
May 21, 2025 08:48AM Benchmark Reiterates Speculative Buy Rating on Intensity Therapeutics, Inc. (INTS)
May 13, 2025 04:10PM
May 13, 2025 04:06PM
Mar 19, 2025 07:34AM
Mar 13, 2025 04:15PM
Mar 13, 2025 04:07PM
Nov 13, 2024 04:06PM
Aug 9, 2024 08:26AM Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 4c
Aug 8, 2024 04:19PM
May 9, 2024 04:08PM
Mar 14, 2024 04:09PM
Nov 13, 2023 08:01AM
Aug 14, 2023 07:54AM
Aug 14, 2023 07:01AM
Aug 7, 2023 07:01AM Intensity Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update
Jul 31, 2023 04:05PM

1,219,026 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All